Survival benefit of early androgen receptor inhibitor therapy in locally advanced prostate cancer: long-term follow-up of the SPCG-6 study

Frederik B Thomsen, Klaus Brasso, Ib J Christensen, Jan-Erik Johansson, Anders Angelsen, Teuvo L J Tammela, Peter Iversen, Scandinavian Prostate Cancer Group

17 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'Survival benefit of early androgen receptor inhibitor therapy in locally advanced prostate cancer: long-term follow-up of the SPCG-6 study'. Sammen danner de et unikt fingeraftryk.

Medicin og biovidenskab